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Treatment of diseases with natural and synthetic materials
has been an aspiration of mankind since the dawn of human
development. From the use of willow-bark to the market-
ing of aspirin, a steady move from folk remedies to the use
of chemistry and biology to develop new therapies has been
observed. In terms of metal-containing drugs, the platinum-
containing drug cisplatin has long been the most eﬀective
metal-containing anticancer drug on the market.
However, severe side eﬀects of conventional drugs are
associated with the inability to distinguish between healthy
and cancer cells. Hence, a concerted world-wide eﬀort is in
progresstodiscoverandcharacterisenewdrugsthatmaydis-
tinguish between healthy and cancer or other diseased cells.
New techniques of drug delivery are sought and the use of
natural products, proteins, antibodies, and synthetic poly-
mers as drug delivery devices capable of targeting a diseased
site is being investigated.
T h e s ei s s u e sa r en i c e l yi l l u s t r a t e db ym a c r o c y c l e ss u c h
as porphyrins, phthalocyanines, and related systems. Some
of these compounds exhibit selective absorption by can-
cer cells and have the ability to photosensitize formation
of singlet oxygen. These attributes have led to the develop-
ment of alternative cancer treatments known as photody-
namic therapy. Sadly, many potentially good new therapeu-
tic agents often never leave the designers’ laboratory due to
some pharmacological problems associated with its in vivo
use. The use of drug delivering devices, including water-
soluble synthetic polymeric drug delivery systems, may help
overcome many pharmacological drug-related problems, in-
cluding those of solubility, speciﬁcity, and biocompatibility,
factors that currently prevent many potentially good thera-
peutic agents from reaching clinics.
The focus of this special issue is the synthesis, character-
isation, physical studies, and application of synthetic metal-
containing complexes and natural occurring proteins in se-
rious human diseases such as cancer, diabetes, arthritis, viral
disease, malaria, and tuberculosis with special focus on the
following:
(a) porphyrins,phthalocyanines,andrelatedcomplexesin
photodynamic cancer therapy;
(b) proteins, enzymes, and synthetic polymeric drug de-
liverysystemsinthetreatmentofcancerandotherdis-
eases;
(c) coordination and organometallic compounds in can-
cer, arthritis, malaria, and viral disease.
Towards these goals, L. Josefsen and R. Boyle describe
in their review article the development and application of
metal-based photosensitisers, including porphyrins and ph-
thalocyanines,inphotodynamictherapy.Fourotherpublica-
t i o n sh i g h l i g h td i ﬀerent aspects of porphyrin-based macro-
cyclic photosensitisers. S. Lee et al. focus on the cellular up-
take and toxicity of thiotetra (ethylene glycol) monomethyl
ether-functionalized porphyrazines. J.-Y. Liu et al. focus on
in vitro photodynamic activity of novel amphiphilic zinc(II)
phthalocyanines bearing oxyethylene-rich substituents. E.
Antunes and T. Nyokong highlight the syntheses and pho-
tophysical properties of tetraazatetrabenzcorrole photosen-
sitizers. Sakamoto et al. present a fundamental study of2 Metal-Based Drugs
zinc bis(1,4-didecylbenzo)-bis(2,3-pyrido)porphyrazine for
application in photodynamic therapy of cancer.
Considering polymeric drug delivery systems, South
African E. Neuse’s excellent review describes the use of syn-
thetic polymers as metal-containing drug delivery vehicles
in medicine. M. David Maree et al. provided a ﬁne treatise
onwhybiocompatible synthetic polymeric drug deliverysys-
tems are becoming increasing popular as drug delivering de-
vices. They also demonstrate the principles behind these sys-
tems in a practical study utilising ferrocene and phthalocya-
nine derivatives anchored on a water-soluble polymeric drug
carrier derived from lysine and aspartic acid. Italians Longo
and Vasapollo demonstrated the use of phthalocyanine-
based molecularly imprinted polymers as nucleoside recep-
tors. X. Sun et al. report on the identiﬁcation of proteins re-
lated to nickel homeostasis in Helicobater pylori by immo-
bilized metal aﬃnity chromatography and two-dimensional
gel electrophoresis. P. Nagababu reported DNA-binding and
photocleavage studies of cobalt (III) ethylenediamine pyri-
dine complexes.
M. Blackie and K. Chibale’s excellent minireview fo-
cuses on metallocene antimalarials. The development of
new metal-containing chemotherapeutic drugs is high-
lighted by contributions from M. Hogan et al. in their syn-
thetic and cytotoxic study of new titanocene analogous.
S. Mahepal et al. look at the in vitro antitumor activ-
ity of novel, mitochondrial-interactive, gold-based lipophilic
cations. Sathisha et al. describe bis-isatin thiocarbohydra-
zone metal complexes and their antitumor activity against
Ehrlich Ascites Carcinoma in Swiss albino mice. In conclu-
sion, J. M. Botha and A. Roodt report mechanistic studies on
trans-aquatetracyanooxo complexes of Re(V) and Tc(V) and
discuss the implications of their results for nuclear medicine.
We hope that this special issue will stimulate new re-
search in all areas of metal-containing drug research and that
it will help to focus research eﬀorts of new and experienced
researchers on key problems in the exciting ﬁeld of metal-
containing drug research.
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